Related Experiment Video
Updated: Sep 20, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Antiplatelet therapy following conservatively managed spontaneous coronary artery dissection
Madeline K Mahowald1, Luis Ortega-Paz2, Claudio Laudani2,3
1Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA. madeline.mahowald@jax.ufl.edu.
Insights
Spontaneous coronary artery dissection (SCAD) requires optimal medical therapy, but current antiplatelet strategies are unclear. This review analyzes data and offers recommendations for antiplatelet use in SCAD patients.
Area of Science:
- Cardiology
- Vascular Medicine
- Interventional Cardiology
Background:
- Spontaneous coronary artery dissection (SCAD) is an uncommon cause of acute coronary syndrome (ACS).
- Optimal medical therapy for SCAD remains undefined.
- Current treatment often follows guidelines for plaque-rupture ACS, using dual antiplatelet therapy (DAPT).
Purpose of the Study:
- To review existing data on antiplatelet therapy in SCAD.
- To analyze the impact of antiplatelet therapy on major adverse cardiac events (MACE) post-SCAD.
- To provide clinical recommendations for antiplatelet management after conservative SCAD treatment.
Main Methods:
- Comprehensive literature review of antiplatelet therapy in SCAD.
- Inclusion of a meta-analysis of observational studies.
- Synthesis of evidence to formulate clinical practice recommendations.
Main Results:
- Observational studies show conflicting results regarding DAPT efficacy in SCAD.
- Evidence supporting standard DAPT in SCAD is limited and derived from different ACS etiologies.
- Further research is needed to clarify optimal antiplatelet strategies.
Conclusions:
- Current recommendations for antiplatelet therapy in SCAD are based on limited evidence.
- Conflicting data necessitates a cautious approach to DAPT in SCAD.
- Clinical practice guidelines should be updated based on specific SCAD data and ongoing research.
Abstract:
Spontaneous coronary artery dissection (SCAD) is a relatively uncommon but increasingly recognized etiology of acute coronary syndrome (ACS). Conservative management is generally recommended, but optimal medical therapy is unknown. The majority of patients are discharged on dual antiplatelet therapy consisting of aspirin and a P2Y12 inhibitor based on trials and guidelines developed for ACS caused by plaque rupture and subsequent platelet activation and aggregation. Observational trials have shown conflicting results on the effects of antiplatelet therapy on major adverse cardiac events after SCAD. This manuscript provides a review of the available data, including a meta- analysis, and offers recommendations for antiplatelet therapy after conservatively managed SCAD in clinical practice.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Acute Coronary Syndrome V: Nursing Management

